Bluejay Diagnostics Stock Analysis

Bluejay Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.49. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bluejay Diagnostics recorded earning per share (EPS) of 657.48. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 29th of January 2026. Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts. Bluejay Diagnostics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 9 people. For more info on Bluejay Diagnostics please contact the company at 844 327 7078 or go to https://bluejaydx.com.

Bluejay Diagnostics Investment Alerts

Bluejay Largest EPS Surprises

View All Earnings Estimates

Bluejay Stock Institutional Investors

Note, although Bluejay Diagnostics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bluejay Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.79 M.

Bluejay Profitablity

Management Efficiency

Bluejay Diagnostics has return on total asset (ROA) of (0.6584) % which means that it has lost $0.6584 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.262) %, meaning that it created substantial loss on money invested by shareholders. Bluejay Diagnostics' management efficiency ratios could be used to measure how well Bluejay Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.4 in 2026. Return On Capital Employed is likely to drop to -1.48 in 2026. At this time, Bluejay Diagnostics' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 42.6 K in 2026, whereas Net Tangible Assets are likely to drop slightly above 6.8 M in 2026.

Technical Drivers

As of the 20th of February, Bluejay Diagnostics shows the Risk Adjusted Performance of (0.17), mean deviation of 4.4, and Standard Deviation of 6.38. Bluejay Diagnostics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Bluejay Diagnostics Price Movement Analysis

Bluejay Diagnostics Insider Trading Activities

Bluejay Diagnostics Outstanding Bonds

Bluejay Diagnostics Predictive Daily Indicators

Bluejay Diagnostics Forecast Models

Bluejay Diagnostics' time-series forecasting models are one of many Bluejay Diagnostics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bluejay Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Bluejay Diagnostics Bond Ratings

Bluejay Diagnostics financial ratings play a critical role in determining how much Bluejay Diagnostics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Bluejay Diagnostics' borrowing costs.

Bluejay Diagnostics Debt to Cash Allocation

Bluejay Diagnostics currently holds 222.25 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Bluejay Diagnostics has a current ratio of 17.06, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Bluejay Diagnostics' use of debt, we should always consider it together with its cash and equity.

Bluejay Diagnostics Total Assets Over Time

Bluejay Diagnostics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Bluejay Diagnostics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Bluejay Diagnostics Debt Ratio

3.65

It appears most of the Bluejay Diagnostics' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Bluejay Diagnostics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Bluejay Diagnostics, which in turn will lower the firm's financial flexibility.

Bluejay Diagnostics Corporate Bonds Issued

Bluejay Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bluejay Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bluejay shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bluejay Diagnostics. By using and applying Bluejay Stock analysis, traders can create a robust methodology for identifying Bluejay entry and exit points for their positions.

When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.